Neurofibromatosis type 1 in childhood

The Journal of Pediatrics

Volumn 116, Issue 6, 1990, Pages 845-853

  Listernick, Robert ^a,b   Charrow, Joel ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFE AU LAIT SPOT; HEREDITY; HUMAN; NEUROFIBROMA; NEUROFIBROMATOSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

CHILD; HUMAN; NEUROFIBROMATOSIS 1;

EID: 0025337504     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(05)80639-0     Document Type: Article

References (70)

1. Further diagnostic thoughts about the elephant man
2. The diagnosis of neurofibromatosis-1 in the child under the age of 6 years
3. Diagnostic importance of café-au-lait spot in neurofibromatosis
4. Axillary freekling as a diagnostic aid in neurofibromatosis
5. Macromelanosomes in the early diagnosis of neurofibromatosis
6. Melanin macroglobules as a cellular marker of neurofibromatosis: a quantitative study
7. Pathology of nerve sheath tumors
8. Neurofibromatosis in children
9. Osseous manifestations of neurofibromatosis in childhood
10. Von Recklinghausen neurofibromatosis: incidence of iris hamartomata
11. Optic gliomas in children with neurofibromatosis type 1
12. Von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata
13. Long-term follow-up of Von Recklinghausen neurofibromatosis: survival and malignant neoplasms
14. Neurofibromatosis and other genetic defects associated with childhood cancer
15. Neurofibromatosis and malignant childhood cancers a survey in Italy 1970–83
16. Childhood neurofibromatosis: risk factors for malignant disease
17. Treatment of children with neurogenic sarcoma
18. Neurofibromatosis and childhood leukemia
19. Association of juvenile xanthogranuloma with juvenile myeloid leukemia
20. Malignancy in neurofibromatosis
21. Rhabdomyosarcoma complicating multiple neurofibromatosis
22. The relationship between nephroblastoma and neurofibromatosis (von Recklinghausen's disease)
23. Neurofibromatosis type 1 (Recklinghausen's disease): neurologic and cognitive assessment with sibling controls
24. Neurofibromatosis implications for learning and behavior
25. Neurofibromatosis and psychological processes
26. The brain in multiple neurofibromatosis (von Recklinghausen's disease): a suggested neuropathological basis for the associated mental defect
27. Precocious puberty associated with neurofibromatosis and optic gliomas
28. A distinctive facial appearance in neurofibromatosis von Recklinghausen
29. Noonan phenotype associated with neurofibromatosis
30. The neurofibromatosis-Noonan syndrome
31. The neurofibromatosis-Noonan syndrome
32. Evidence that the “neurofibromatosis-Noonan syndrome” is a variant of von Recklinghausen neurofibromatosis
33. Noonan syndrome and neurofibromatosis type 1 segregating independently in a family
34. Multiple neurofibromatosis (von Recklinghausen's disease) and its inheritance with description of a case
35. The von Reckinghausen neurofibromatosis region on chromosome 17: genetic and physical maps come into focus
36. The pathophysiology of neurofibromatosis. IX. Paternal age as a factor in the origin of new mutations
37. Discounting an adverse maternal effect of severity of neurofibromatosis
38. Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17
39. Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene
40. Cases of neurofibromatosis with rearrangements of chromosome 17 involving band 17q11.2
41. Precise localization of NF1 to 17q11.2 by balanced translocation
42. Multipoint linkage analysis in neurofibromatosis type 1: an international collaboration
43. Neurofibromatosis: the quintessential neurocristopathy: pathogenetic concepts and relationships
44. Investigations on the neural crest methodologic aspects and recent advances
45. The regulation of normal and abnormal neural crest cell development
46. The biology and mechanism of action of nerve growth factor
47. Nerve growth factor receptors on dissociated neurofibroma Schwann-like cells
48. Schwann-like cells cultured from human dermal neurofibromas
49. Induction of nerve growth factor receptors in Schwann cells after axotomy
50. Increased nerve-growth stimulating activity in disseminated neurofibromatosis
51. Nerve-growth factor in disseminated neurofibromatosis
52. A discordant sibship analysis between beta-NGF and neurofibromatosis
53. Models for inherited susceptibility to cancer in the nervous system: a molecular-genetic approach to neurofibromatosis
54. Neurofibromatosis fibroblasts: abnormal growth and binding to epidermal growth factor
55. Serum neuronal growth factor levels in von Recklinghausen's neurofibromatosis
56. Glial growth factor-like activity in Schwann cell tumors
57. Pathophysiology of neurofibromatosis
58. Mast-cell stabilization to decrease neurofibroma growth
59. The significance of MRI abnormalities in children with neurofibromatosis
60. Management of a patient with neurofibromatosis and brainstem lesion
61. Neuroaudiologic abnormalities in patients with type 1 neurofibromatosis
62. Controversy in the management of optic nerve glioma
63. Chiasmatic optic glioma treated with chemotherapy a preliminary report
64. Carboplatinum in the treatment of recurrent childhood brain tumors
65. Neurofibromatosis 2 clinical and DNA linkage studies of a large kindred
66. Neurofibromatosis 2
67. Segmental neurofibromatosis
68. Familial transmission of segmental neurofibromatosis